Professional Documents
Culture Documents
Respirology Section
Respirology Section
SABAs:
- monotx is not recommended for most pts with mild sxs
- compatible for childhood, pregnancy and BF
- Have an onset of 5-15 min and with a shorter duration of action of 3-6 hours to treat the
acute phase
- If SABAs do not provide adequate relief, may be a sign of worsening asthma of incorrect
diagnosis
Asthma severity:
- classified based on the level of tx that is required to treat the sxs and exacerbations
ICS – show a reduction in asthma sxs, improvement in lung function (FEV1), reduction in
mortality, asthma exacerbations and hospitalization and improve QOL
- they do not cure asthma but they influence airway remodelling and reduce bronchial
hyperreactivity
- sx control can occur within days of regular use but reduction in airway
hyperresponsiveness may take months
- Local a/e of iCS= hoarseness, dysphonia, oral candidiasis, sore throat and metallic taste
o minimized through using an aero chamber or washing mouth after using
o Risk of systemic AE (osteoporosis, cataracts, glaucoma, adrenal suppression) –
inc with long term use of high dose ICS, use of more potent formulations
(fluticasone, mometasone) and frequent use of oral ICS to treat exacerbations
o Reduced growth rate and use of ICS
- Asthma in pregnancy should be treated the same as non-pregnant ppl (can lead to
complications for the baby – low birth weight, increased perinatal mortality and pre-
eclampsia). Amongst ICS – bud is most preferred, most studied.
- ONLY agent to be cautious of: theophylline due to its narrow therapeutic index
16 year old, history of asthma + eczema. NKDA. Just discharged from hospital following severe
asthma exacerbation:
- Salbutamol via spacer should be administered at inc doses q20min
- A short course from 5-14 days of prednisone should be initiated
- Should be prescribed controller tx or have its dose inc for 1-2 weeks
- No need for antibiotics for asthma exacerbations
Oral CS s/e: increase BG, BP, mood disturbances. Not likely to cause diarrhea.
- Oral thrush can be prevented by using a spacer device with an MDI when using ICS +
rinsing mouth afterwards
- No interaction bw nystatin + asthma meds
MDIs:
- MDIs with aerochambers are recommended for children <6
- MDIs are pressurized inhalers that use a chemical propellant to release the medication
- Shake the MDI before each use
- Should wait 15-30 sec before taking a second pull of the same medication
Turbuhalers
- they are DPIs
- Do not require the pt to coordinate the administration of the dose with their breath
(unlike MDIs, there is no coordination required when administering a turbuhaler)
- Include dose indicators
- The inhaler is breath activated and involves turning of the colored wheel to load the
dose
19 year old male, uncontrolled asthma maybe due to new dog. Day time sxs 3x/wk and night
awakenings 1x/week. Currently using Symbicort prn – what is the most appropriate course?
- Initiate low dose ICS (first line when starting) – also even tho he has sxs of nocturnal
awakening, in adults you would not inc to a medium dose ICS right away
15 year old, uncontrolled asthma. Has been using a low dose ICS which he started a few months
ago but it isn’t working. Using Symbicort prn. Asthma disruption QOL:
- Switch the controller med from ICS to an ICS/LABA combination – this has shown to
reduce the rates of asthma exacerbations + hospitalizations
25 year old female, on fluticasone/salmeterol 250/50 for many years, no exacerbation in 2 yrs
and rarely uses SABA (1x/month). Recommend step down
LABAs
- vilanterol is approved for once daily as opposed to salmeterol and formoterol which
have a shorter duration of action
- LABA/ICS has shown a reduction in exacerbations and helps to reduce exercise-induced
bronchospasm
- Bud/for can be used as both a reliever and cotroller for asthma management
- LABAs are not the preferred step up in tx for kids 6-11 as increasing the dose of ICS is
preferred
Prednisone is generally safe during BF, should be taken earlier in the day to avoid insomnia, and
take with food.
COPD – spirometry/imaging is not used to monitor tx. Performed once a year only if there is an
indication.
Asthma exacerbatins risk factors: poor medication adherence, current smoker, ICU admission
for asthma
Local AE of iCS: hoarseness, sore throat, oral candidiasis. (Adrenal suppression is a systemic
effect and occurs after long term use of high doses)
Aerochambers:
- Reduces risk of oral cadidiassis due to more effective lung deposition
- Facilitates the action of breathing in while activating the MDI
- A spacer should be replaced with a new one after a year of continuous use
- If a whistling sound is heard it indicates that the pt is breating too fast
Omalizumab – there are several biologic agents that can be considered as add on tx in asthma.
Omalizumab is used in severe persistent allergic asthma. Common AE= injection site rxns, URTI,
headaches and hypersensitivity rxn. Constipation is NOT an AE.